Verona Pharma plc (VRNA)
NASDAQ: VRNA · IEX Real-Time Price · USD
15.47
+0.16 (1.05%)
At close: Apr 26, 2024, 4:00 PM
15.74
+0.27 (1.75%)
After-hours: Apr 26, 2024, 4:11 PM EDT

Verona Pharma Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
79
Market Cap
1.20B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 2022458.00K-39.54M-98.86%
Dec 31, 202140.00M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Omnicell 1.15B
Pacira BioSciences 674.98M
Phreesia 356.30M
Kiniksa Pharmaceuticals 270.26M
Xencor 168.34M
Deciphera Pharmaceuticals 163.36M
4D Molecular Therapeutics 20.72M
Tarsus Pharmaceuticals 17.45M
Revenue Rankings